Sigyn Therapeutics, Inc.
Sigyn Therapeutics develops dialysis-like therapies for cardiovascular disease and cancer. Their therapies are designed to improve patient quality of life. Key products include CardioDialysis™ for cardiovascular disease, and ImmunePrep™, ChemoPrep™ and ChemoPure™ for cancer therapy.
Registro Oficial
Última verificación: 1/2/2026
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
Context Therapeutics Inc.
Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.
AGENUS INC
Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.
Olema Pharmaceuticals, Inc.
Olema Oncology is a pharmaceutical company focused on developing innovative medicines for breast cancer and other cancers. They strive to create better treatments that help patients feel better and live longer. Olema is publicly traded on Nasdaq and engaged in the research and development of novel therapies.